Dimed Distribuidora de Medicamentos (BSP:PNVL3) Interest Expense : R$-124 Mil (TTM As of Dec. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Dimed Distribuidora de Medicamentos Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Dimed Distribuidora de Medicamentos's interest expense for the three months ended in Dec. 2024 was R$ -28 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was R$-124 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Dimed Distribuidora de Medicamentos's Operating Income for the three months ended in Dec. 2024 was R$ 61 Mil. Dimed Distribuidora de Medicamentos's Interest Expense for the three months ended in Dec. 2024 was R$ -28 Mil. Dimed Distribuidora de Medicamentos's Interest Coverage for the quarter that ended in Dec. 2024 was 2.21. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Dimed Distribuidora de Medicamentos Interest Expense Historical Data

The historical data trend for Dimed Distribuidora de Medicamentos's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimed Distribuidora de Medicamentos Interest Expense Chart

Dimed Distribuidora de Medicamentos Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-35.31

-37.12

-70.03

-102.57

-104.88

Dimed Distribuidora de Medicamentos Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-25.71	-25.34	-36.62	-34.25	-27.50

Dimed Distribuidora de Medicamentos Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-124 Mil.

Dimed Distribuidora de Medicamentos (BSP:PNVL3) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Dimed Distribuidora de Medicamentos's Interest Expense for the three months ended in Dec. 2024 was R$-28 Mil. Its Operating Income for the three months ended in Dec. 2024 was R$61 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was R$943 Mil.

Dimed Distribuidora de Medicamentos's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	60.812	/	-27.502
	=	2.21

The higher the ratio, the stronger the company's financial strength is.

Dimed Distribuidora de Medicamentos Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dimed SA Distribuidora de Medicamentos (BSP:PNVL3) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000

Website

https://www.grupopanvel.com.br

Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its segments are divided into Retail, Wholesale and Corporate. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. The Wholesale segment is the distributor of drugs in Brazil. The Corporate segment includes Wholesale and Retail, as well as the subsidiary Lifar. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.

Dimed Distribuidora de Medicamentos Headlines

No Headlines